A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.
Ross et al.
Prostate Cancer and Prostatic Diseases
August 2019
Authors and Affiliates
Ross AE1, Hurley PJ2,3,4, Tran PT4,5,6, Rowe SP6, Benzon B2, Neal TO3,4, Chapman C3,4, Harb R3,4, Milman Y3,4, Trock BJ2,3,4, Drake CG7, Antonarakis ES2,3,4;
1
Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA. ashley.ross@usoncology.com.
2
Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
3
The Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
4
The Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
5
The Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
6
The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.
7
The Department of Medicine, Columbia University, New York, NY, USA.